Christopher Mills

Insider Reports History

Location
C/O Renalytics Plc, Finsgate, 5 7 Cranwood Street, London, United Kingdom
Signature
/s/ Katie Kazem, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Mills:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Renalytix plc Director, 10%+ Owner Ordinary Shares 6.46M $1.61M $0.25 Jul 1, 2023 By North Atlantic Smaller Companies Investment Trust plc
Renalytix plc Director, 10%+ Owner Ordinary Shares 2.81M $703K $0.25 Jul 1, 2023 By Oryx International Growth Fund Limited
Renalytix plc Director, 10%+ Owner Ordinary Shares 801K $200K $0.25 Jul 1, 2023 By Harwood Capital LLP
Renalytix plc Director, 10%+ Owner Employee Stock Option (right to buy) 95K Nov 20, 2023 Direct

Insider Reports Filed by Christopher Mills

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RNLX Renalytix plc Nov 20, 2023 1 $0 4 Nov 22, 2023 Director, 10%+ Owner
RNLX Renalytix plc Jul 1, 2023 0 $0 3 Jul 3, 2023 Director, 10%+ Owner